*Edited by Manuela Fiuza*

The possibility of getting a cardiovascular disease or cancer increases with advancing age. At the same time, relevant improvements in cancer therapy have resulted in the improvement of quality of life and the increasement of the survival rate of such patients. As a result we have larger number of patients that experience the cardiac side effects of chemotherapy. The extent of cardiotoxicity is variable, depending on the type of drug used, combination with other drugs, prior mediastinal radiotherapy and the presence of cardiovascular risk factors or history of heart disease. Early detection of the patients proneness for developing cardiotoxicity is the key issue to decrease morbidity and mortality. It also facilitates more tailored therapeutic interventions. Therefore, the collaboration and interaction of cardiology and oncology may contribute to reducing the cardiovascular adverse effects and improving the results in the treatment of patients with cancer.

ISBN 978-953-51-0273-1

Cardiotoxicity of Oncologic Treatments

Photo by Max2611 / iStock

## Cardiotoxicity of Oncologic Treatments

*Edited by Manuela Fiuza*

**CARDIOTOXICITY OF** 

Edited by **Manuela Fiuza**

**ONCOLOGIC TREATMENTS** 

## **CARDIOTOXICITY OF ONCOLOGIC TREATMENTS**

Edited by **Manuela Fiuza**

http://dx.doi.org/10.5772/2170 Edited by Manuela Fiuza

#### **Contributors**

Xinhua Yan, David Goukassian, James Morgan, Elena Kinova, Assen Goudev, Manuela Fiuza, Andreia Magalhaes, Beata Mlot, Piotr Rzepecki, Victoria Chagoya De Sanchez, Vukosava Milic Torres, Viktorija Dragojevic-Simic, Robert Frangez, Marjana Grandič, Milka Vrecl

#### **© The Editor(s) and the Author(s) 2012**

The moral rights of the and the author(s) have been asserted.

All rights to the book as a whole are reserved by INTECH. The book as a whole (compilation) cannot be reproduced, distributed or used for commercial or non-commercial purposes without INTECH's written permission. Enquiries concerning the use of the book should be directed to INTECH rights and permissions department (permissions@intechopen.com).

Violations are liable to prosecution under the governing Copyright Law.

Individual chapters of this publication are distributed under the terms of the Creative Commons Attribution 3.0 Unported License which permits commercial use, distribution and reproduction of the individual chapters, provided the original author(s) and source publication are appropriately acknowledged. If so indicated, certain images may not be included under the Creative Commons license. In such cases users will need to obtain permission from the license holder to reproduce the material. More details and guidelines concerning content reuse and adaptation can be foundat http://www.intechopen.com/copyright-policy.html.

#### **Notice**

Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book.

First published in Croatia, 2012 by INTECH d.o.o. eBook (PDF) Published by IN TECH d.o.o. Place and year of publication of eBook (PDF): Rijeka, 2019. IntechOpen is the global imprint of IN TECH d.o.o. Printed in Croatia

Legal deposit, Croatia: National and University Library in Zagreb

Additional hard and PDF copies can be obtained from orders@intechopen.com

Cardiotoxicity of Oncologic Treatments Edited by Manuela Fiuza p. cm. ISBN 978-953-51-0273-1 eBook (PDF) ISBN 978-953-51-6893-5
